𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

✍ Scribed by Erin R. King; Zhifei Zu; Yvonne T.M. Tsang; Michael T. Deavers; Anais Malpica; Samuel C. Mok; David M. Gershenson; Kwong-Kwok Wong

Book ID
113963287
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
899 KB
Volume
123
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The activated transforming growth factor
The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer
✍ Shogo Yamamura; Noriomi Matsumura; Masaki Mandai; Zhiqing Huang; Tomonori Oura; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 529 KB

## Abstract Peritoneal dissemination including omental metastasis is the most frequent route of metastasis and an important prognostic factor in advanced ovarian cancer. We analyzed the publicly available microarray dataset (GSE2109) using binary regression and found that the transforming growth fa

Plasma insulin-like growth factor 1 is p
Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993–2004
✍ Katharina Nimptsch; Elizabeth A. Platz; Michael N. Pollak; Stacey A. Kenfield; M πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 151 KB πŸ‘ 1 views

## Abstract The insulin‐like growth factor (IGF) axis plays a role in growth and progression of prostate cancer. High circulating IGF‐1 levels have been associated with an increased risk of prostate cancer. Results for IGF binding protein 3 (IGFBP‐3) are inconclusive. Some studies have indicated th